Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.

Rahier JF, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y, Cottone M, de Ridder L, Doherty G, Ehehalt R, Esteve M, Katsanos K, Lees CW, Macmahon E, Moreels T, Reinisch W, Tilg H, Tremblay L, Veereman-Wauters G, Viget N, Yazdanpanah Y, Eliakim R, Colombel JF; European Crohn's and Colitis Organisation (ECCO).

J Crohns Colitis. 2014 Jun;8(6):443-68. doi: 10.1016/j.crohns.2013.12.013. Epub 2014 Mar 6. No abstract available.

2.

Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease.

Walsh AJ, Weltman M, Burger D, Vivekanandarajah S, Connor S, Howlett M, Radford-Smith G, Selby W, Veillard AS, Grimm MC, Travis SP, Lawrance IC.

J Crohns Colitis. 2013 Nov;7(10):e449-56. doi: 10.1016/j.crohns.2013.02.019. Epub 2013 Apr 17.

PMID:
23601754
3.

Epidemiology and prevention of viral infections in patients with hematologic malignancies.

Angarone M.

Infect Disord Drug Targets. 2011 Feb;11(1):27-33. Review.

PMID:
21303338
4.

Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease.

Gisbert JP, Chaparro M, Esteve M.

Aliment Pharmacol Ther. 2011 Mar;33(6):619-33. Review.

PMID:
21416659
5.

Infectious complications following renal transplantation.

Sia IG, Paya CV.

Surg Clin North Am. 1998 Feb;78(1):95-112. Review.

PMID:
9531938
6.

Prevention of opportunistic infections in patients with inflammatory bowel disease and implications of the ECCO consensus in Belgium.

Rahier JF, Moreels T, De Munter P, D'Haens G.

Acta Gastroenterol Belg. 2010 Jan-Mar;73(1):41-5.

PMID:
20458849
7.

[Pocket guide to invasive mycoses in onco-hematologic patients].

Bermúdez A, Carreras E, De la Cámara R, Eraso E, Fortún J, García-Ruiz JC, Guarro J, Jarque I, Marcos de Lucas E, Mayayo E, Pastor FJ, Pemán J, Pontón J, Quindós G, Salavert M, Sanz MA, Zaragoza R.

Rev Iberoam Micol. 2009;Suppl:3-199. Spanish. No abstract available.

8.

[Reactivation in immunosuppression. Complicated hepatitis comeback].

[No authors listed]

MMW Fortschr Med. 2004 Sep 23;146(39):5-6. German. No abstract available.

PMID:
15662732
9.

Opportunistic infections in paediatric inflammatory bowel disease patients.

De Greef E, Vandenplas Y, Veereman-Wauters G.

Arch Dis Child. 2012 Jan;97(1):5-7. doi: 10.1136/archdischild-2011-300365. Epub 2011 Sep 7. Review. No abstract available.

PMID:
21903596
10.

The European (ECCO) Consensus on infection in IBD: what does it change for the clinician?

Rahier JF, Yazdanpanah Y, Colombel JF, Travis S.

Gut. 2009 Oct;58(10):1313-5. doi: 10.1136/gut.2008.175950. No abstract available.

PMID:
19749130
11.

Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America.

Masur H, Brooks JT, Benson CA, Holmes KK, Pau AK, Kaplan JE; National Institutes of Health; Centers for Disease Control and Prevention; HIV Medicine Association of the Infectious Diseases Society of America.

Clin Infect Dis. 2014 May;58(9):1308-11. doi: 10.1093/cid/ciu094. Epub 2014 Feb 27.

12.

Prevention and management of infectious complications in IBD.

Rahier JF.

Dig Dis. 2012;30(4):408-14. doi: 10.1159/000338143. Epub 2012 Jul 12. Review.

PMID:
22796807
13.

[Infections with hepatitis B, C and delta viruses in patients with AIDS].

Stazka J, Babiuch L, Mian M, Szymańska B, Kamińska E, Panfist E, Kowalska T, Poznańska-Linde H.

Przegl Epidemiol. 1991;45(4):343-6. Polish.

PMID:
1668702
14.

[Fungal infection in patients with granulocytopenia. Pathogenetic, diagnostic and therapeutic aspects].

Piatkowska-Jakubas B, Skotnicki AB.

Przegl Lek. 1994;51(10):447-51. Review. Polish.

PMID:
7878200
15.

The urgent need for HIV and hepatitis prevention in drug treatment programs in Hungary.

Gyarmathy VA, Rácz J, Neaigus A, Ujhelyi E.

AIDS Educ Prev. 2004 Jun;16(3):276-87.

16.

Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis.

Viget N, Vernier-Massouille G, Salmon-Ceron D, Yazdanpanah Y, Colombel JF.

Gut. 2008 Apr;57(4):549-58. doi: 10.1136/gut.2006.114660. Epub 2008 Jan 4. Review.

PMID:
18178610
17.

Bacterial and fungal infections after kidney transplantation.

Schmidt A, Oberbauer R.

Curr Opin Urol. 1999 Jan;9(1):45-9. Review.

PMID:
10726071
18.

Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons.

Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, Rich JD.

Am J Public Health. 2004 Jul;94(7):1218-23. Erratum in: Am J Public Health. 2004 Nov;94(11):1847.

19.

Opportunistic viral hepatitis in liver transplant recipients.

Markin RS, Langnas AN, Donovan JP, Zetterman RK, Stratta RJ.

Transplant Proc. 1991 Feb;23(1 Pt 2):1520-1. No abstract available.

PMID:
1846476
20.

A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease.

Naganuma M, Kunisaki R, Yoshimura N, Takeuchi Y, Watanabe M.

J Gastroenterol. 2013 May;48(5):595-600. doi: 10.1007/s00535-012-0686-9. Epub 2012 Oct 5.

PMID:
23053426
Items per page

Supplemental Content

Write to the Help Desk